Raising awareness of cardiovascular diseases: A silent killer in South Africa

Main Article Content

Mteto Qhayiya Fihla*

Abstract

Cardiovascular Disease (CVD) is the leading cause of death in Non-Communicable Diseases (NCDs) in the Republic of South Africa (RSA), surpassing all cancers combined. It is estimated that the disease is responsible for 215 deaths daily, with a 17.3% death rate. Common risk factors for the disease include hypertension, diabetes, hypercholesteremia, overweight and obesity, smoking, and stress. Contrary to well-known diseases like HIV/AIDS and TB, CVD does not enjoy enough publicity and attention from the population. This indicates a lack of awareness and concern for the disease among the general people, resulting in the disease being a continued burden on the healthcare system of RSA. The objective of this study was to examine the aetiology and classifications of CVD, identify cardiovascular risk factors, and explore strategies for preventing and managing the condition.

Downloads

Download data is not yet available.

Article Details

Fihla, M. Q. (2024). Raising awareness of cardiovascular diseases: A silent killer in South Africa. Journal of Cardiovascular Medicine and Cardiology, 11(1), 013–017. https://doi.org/10.17352/2455-2976.000203
Review Articles

Copyright (c) 2024 Fihla MQ.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

The Heart and Stroke Foundation South Africa, 2016. Cardiovascular disease statistics reference document. Accessed November 29, 2023. https://www.heartfoundation.co.za/wp- content/uploads/2017/10/CVD-Stats-Reference-Document-2016-FOR-MEDIA-1.pdf.

Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 2021 Jan 23;5:100149. doi: 10.1016/j.ajpc.2021.100149. PMID: 34327491; PMCID: PMC8315386.

Statistics South Africa, 2019. Mortality and causes of death in South Africa: Findings from death notification. Accessed November 25, 2023. https://www.statssa.gov.za/publications/P03093/P030932019.pdf.

Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021 Nov;18(11):785-802. doi: 10.1038/s41569-021-00559-8. Epub 2021 May 28. PMID: 34050340; PMCID: PMC8162166.

Amran, M.S., Bahar, N.B. and Akash, S., 2022. Physiology and Pathology of the Cardiovascular System. In Cardiovascular Diseases. IntechOpen.

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25. PMID: 32247212; PMCID: PMC7102662.

Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed). 2021 Jun 11;156(11):547-554. doi: 10.1016/j.medcle.2020.12.021. Epub 2021 Jun 5. PMID: 34109276; PMCID: PMC8178966.

Shao C, Wang J, Tian J, Tang YD. Coronary Artery Disease: From Mechanism to Clinical Practice. Adv Exp Med Biol. 2020; 1177:1-36. doi: 10.1007/978-981-15-2517-9_1. PMID: 32246442.

Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of Ischemic Heart Disease. Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373. PMID: 30354347.

Haider R. Peripheral vascular disease. Cardiology Research and Reports. 2023; 5(4).

Jain P, Kulkarni AP, Bhosale SJ. Peripheral Vascular Disease. Objective Anesthesia Review: A Comprehensive Textbook for the Examinee. 2020; 69.

Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021 May;18(5):331-348. doi: 10.1038/s41569-020-00472-6. Epub 2020 Dec 22. PMID: 33353985.

Ogino H, Iida O, Akutsu K, Chiba Y, Hayashi H, Ishibashi-Ueda H, et al. Japanese Circulation Society, the Japanese Society for Cardiovascular Surgery, the Japanese Association for Thoracic Surgery and the Japanese Society for Vascular Surgery Joint Working Group. JCS/JSCVS/JATS/JSVS 2020 Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection. Circ J. 2023 Sep 25;87(10):1410-1621. doi: 10.1253/circj.CJ-22-0794. Epub 2023 Sep 1. PMID: 37661428.

Murphy SJ, Werring DJ. Stroke: causes and clinical features. Medicine (Abingdon). 2020 Sep;48(9):561-566. doi: 10.1016/j.mpmed.2020.06.002. Epub 2020 Aug 6. PMID: 32837228; PMCID: PMC7409792.

Ali JS, Ramadan RMES, Aboushady RMN. Stroke Rehabilitation Strategies to Enhance Activities of Daily Living. LAP LAMBERT Academic Publishing. 2020.

Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023 Oct 5;389(14):1273-1285. doi: 10.1056/NEJMoa2206916. Epub 2023 Aug 26. PMID: 37632466; PMCID: PMC10589462.

Kohli-Lynch CN, Erzse A, Rayner B, Hofman KJ. Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study. BMJ Open. 2022 Feb 22;12(2):e055621. doi: 10.1136/bmjopen-2021-055621. PMID: 35193918; PMCID: PMC8867372.

Nwabuo CC, Vasan RS. Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy. Curr Hypertens Rep. 2020 Feb 3;22(2):11. doi: 10.1007/s11906-020-1017-9. PMID: 32016791.

Turana Y, Tengkawan J, Chia YC, Nathaniel M, Wang JG, Sukonthasarn A, Chen CH, Minh HV, Buranakitjaroen P, Shin J, Siddique S, Nailes JM, Park S, Teo BW, Sison J, Ann Soenarta A, Hoshide S, Tay JC, Prasad Sogunuru G, Zhang Y, Verma N, Wang TD, Kario K; HOPE Asia Network. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia. J Clin Hypertens (Greenwich). 2021 Mar;23(3):513-521. doi: 10.1111/jch.14099. Epub 2020 Nov 15. PMID: 33190399; PMCID: PMC8029540.

Elsaid N, Saied A, Kandil H, Soliman A, Taher F, Hadi M, Giridharan G, Jennings R, Casanova M, Keynton R, El-Baz A. Impact of stress and hypertension on the cerebrovasculature. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1643-1652. doi: 10.52586/5057. PMID: 34994178.

Mahalakshmi, M., 2019. Correlation between Interarm Systolic Blood Pressure Difference and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease and Stroke (Doctoral dissertation, Madurai Medical College, Madurai). http://repository-tnmgrmu.ac.in/11118/1/200500319mahalakshmi.pdf

Frąk W, Wojtasińska A, Lisińska W, Młynarska E, Franczyk B, Rysz J. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. Biomedicines. 2022 Aug 10;10(8):1938. doi: 10.3390/biomedicines10081938. PMID: 36009488; PMCID: PMC9405799.

Bassareo PP, O'Brien ST, Dunne E, Duignan S, Martino E, Martino F, Mcmahon CJ. Should We Be Screening for Ischaemic Heart Disease Earlier in Childhood? Children (Basel). 2022 Jun 30;9(7):982. doi: 10.3390/children9070982. PMID: 35883966; PMCID: PMC9320497.

Mezil SA, Abed BA. Complication of diabetes mellitus. Annals of the Romanian Society for Cell Biology. 2021; 1546-1556.

Naser IH, Alkareem ZA, Mosa AU. Hyperlipidemia: pathophysiology, causes, complications, and treatment. A review. Karbala Journal of Pharmaceutical Sciences. 2021; 1(19).

AL-Ezzy AIA, Hameed MS. The Physiological Aspects of Hyperlipidemia in Health and Disease. Diyala Journal for Veterinary Sciences. 2021; 1(2):1-9.

Manafe M, Chelule PK, Madiba S. The Perception of Overweight and Obesity among South African Adults: Implications for Intervention Strategies. Int J Environ Res Public Health. 2022 Sep 28;19(19):12335. doi: 10.3390/ijerph191912335. PMID: 36231633; PMCID: PMC9564787.

Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Circ Res. 2021 Apr 2;128(7):951-968. doi: 10.1161/CIRCRESAHA.121.318093. Epub 2021 Apr 1. PMID: 33793327; PMCID: PMC8026272.

Cintron SA, Shen Q, Mahoney D, Sardiu ME, Hiebert JB, Pierce J. Obesity-Related High-Output Heart Failure: An Integrative Review. J Cardiovasc Nurs. 2022 Sep 29. doi: 10.1097/JCN.0000000000000939. Epub ahead of print. PMID: 36178329.

Tohirova J, Shernazarov F. Atherosclerosis: causes, symptoms, diagnosis, treatment and prevention. Science and innovation. 2022; 1(D5):7-12.

Wang W, Zhao T, Geng K, Yuan G, Chen Y, Xu Y. Smoking and the Pathophysiology of Peripheral Artery Disease. Front Cardiovasc Med. 2021 Aug 27;8:704106. doi: 10.3389/fcvm.2021.704106. PMID: 34513948; PMCID: PMC8429807.

Razaaq HAA. A Short Review: Genetic Risk Factors of Stroke. Journal of University of Anbar for Pure Science. 2021; 15(2):20-26.

Klein LW. Systemic and Coronary Hemodynamic Effects of Tobacco Products on the Cardiovascular System and Potential Pathophysiologic Mechanisms. Cardiol Rev. 2022 Jul-Aug 01;30(4):188-196. doi: 10.1097/CRD.0000000000000395. Epub 2021 May 12. PMID: 34001689.

Chu B, Marwaha K, Sanvictores T, Ayers D. Physiology, stress reaction. In StatPearls . StatPearls Publishing. 2021.

Jones C, Gwenin C. Cortisol level dysregulation and its prevalence-Is it nature's alarm clock? Physiol Rep. 2021 Jan;8(24):e14644. doi: 10.14814/phy2.14644. PMID: 33340273; PMCID: PMC7749606.

Osborne MT, Shin LM, Mehta NN, Pitman RK, Fayad ZA, Tawakol A. Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease. Circ Cardiovasc Imaging. 2020 Aug;13(8):e010931. doi: 10.1161/CIRCIMAGING.120.010931. Epub 2020 Aug 14. PMID: 32791843; PMCID: PMC7430065.

Yannakoulia M, Panagiotakos D. Weight loss through lifestyle changes: impact in the primary prevention of cardiovascular diseases. Heart. 2021 Sep;107(17):1429-1434. doi: 10.1136/heartjnl-2019-316376. Epub 2020 Nov 20. PMID: 33219107.

Kaminsky LA, German C, Imboden M, Ozemek C, Peterman JE, Brubaker PH. The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease. Prog Cardiovasc Dis. 2022 Jan-Feb;70:8-15. doi: 10.1016/j.pcad.2021.12.001. Epub 2021 Dec 16. PMID: 34922952.

Korczak R, Slavin JL. Definitions, regulations, and new frontiers for dietary fiber and whole grains. Nutr Rev. 2020 Aug 1;78(Suppl 1):6-12. doi: 10.1093/nutrit/nuz061. PMID: 32728750.

Adamczak M, Wiecek A. Food Products That May Cause an Increase in Blood Pressure. Curr Hypertens Rep. 2020 Jan 8;22(1):2. doi: 10.1007/s11906-019-1007-y. PMID: 31915940.

Magutah K, Thairu K, Patel N. Effect of short moderate intensity exercise bouts on cardiovascular function and maximal oxygen consumption in sedentary older adults. BMJ Open Sport Exerc Med. 2020 Feb 28;6(1):e000672. doi: 10.1136/bmjsem-2019-000672. PMID: 32180993; PMCID: PMC7050352.

Katzmarzyk PT, Jakicic JM. Physical Activity for Health-Every Minute Counts. JAMA. 2023 Jul 18;330(3):213-214. doi: 10.1001/jama.2023.11014. PMID: 37462698.

Patient. Alcohol and Sensible Drinking – Safe Limits of Alcohol. 2023. https://cardensurgery.co.uk/wp-content/uploads/2020/05/Alcohol-Safe-Limits.pdf.

Scannapieco FA, Gershovich E. The prevention of periodontal disease-An overview. Periodontol 2000. 2020 Oct;84(1):9-13. doi: 10.1111/prd.12330. PMID: 32844421.

Hersi M, Beck A, Hamel C, Esmaeilisaraji L, Pussegoda K, Austin B, Ahmadzai N, Pratt M, Thuku M, Yazdi F, Bennett A. Effectiveness of stop smoking interventions among adults: an overview of systematic reviews. 2023. DOI: https://doi.org/10.21203/rs.3.rs-3743616/v1

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Cifkova R, Davletov K, Dilic M, Dolzhenko M, Gaita D, Gotcheva N, Hasan-Ali H, Jankowski P, Lionis C, Mancas S, Milićić D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Ž, Vulić D, Wood D; EUROASPIRE V Investigators. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2021 May 8;28(4):370-379. doi: 10.1177/2047487320908698. Epub 2020 Mar 20. PMID: 33966079.

O'Toole RV, Stein DM, Frey KP, O'Hara NN, Scharfstein DO, Slobogean GP, Taylor TJ, Haac BE, Carlini AR, Manson TT, Sudini K, Mullins CD, Wegener ST, Firoozabadi R, Haut ER, Bosse MJ, Seymour RB, Holden MB, Gitajn IL, Goldhaber SZ, Eastman AL, Jurkovich GJ, Vallier HA, Gary JL, Kleweno CP, Cuschieri J, Marvel D, Castillo RC; METRC. PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients. BMJ Open. 2021 Mar 24;11(3):e041845. doi: 10.1136/bmjopen-2020-041845. PMID: 33762229; PMCID: PMC7993181.

Zhou Z, Lin Y, Zhou Z, Lin Y, Zhou Z, Lin Y, Zhou Z, Lin Y, Zhou Z, Lin Y. Cardiovascular disease. In Clinical Molecular Diagnostics. 2021; 583-594.

Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A. Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events. Pharmacol Ther. 2023 Oct; 250:108507. doi: 10.1016/j.pharmthera.2023.108507. Epub 2023 Aug 9. PMID: 37567512.